INNOVIVA
Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.
INNOVIVA
Social Links:
Industry:
Biotechnology Financial Services Pharmaceutical
Founded:
1996-11-01
Status:
Active
Contact:
877-275-8479
Total Funding:
225 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Current Advisors List
Current Employees Featured
Stock Details
Company's stock symbol is NASDAQ:INVA
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-11 | La jolla Pharmaceutical | La jolla Pharmaceutical acquired by Innoviva | 149 M USD |
| 2022-05-23 | Entasis Therapeutics | Entasis Therapeutics acquired by Innoviva | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-09 | Armata Pharmaceuticals | Innoviva investment in Post-IPO Equity - Armata Pharmaceuticals | 45 M USD |
| 2021-10-28 | Armata Pharmaceuticals | Innoviva investment in Post-IPO Equity - Armata Pharmaceuticals | 7 M USD |
| 2020-10-21 | InCarda Therapeutics | Innoviva investment in Series C - InCarda Therapeutics | 30 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-05-21 | Innoviva Names Pavel Raifeld as Chief Executive Officer |